CareLit Fachartikel

A balanced activation of regulatory subunits of phosphoinositide 3-kinase defines proliferation and survival in pancreatic beta-cells

D Hörsch, P Niebel, J Schrader · Diabetologie und Stoffwechsel · 2006 · Heft 06

Dokument
1134021
CareLit-ID
Jahr
2006
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Diabetologie und Stoffwechsel
Autor:innen
D Hörsch, P Niebel, J Schrader
Ausgabe
Heft 06 / 2006
Seiten
–
Erschienen: 2006-06-19 00:00:00
ISSN
1861-9002

Zusammenfassung

Protein kinase B (PKB; also known as Akt) is pivotal for beta-cell growth and survival. The main activator of PKB is the lipid kinase phosphinositide 3-kinase (PI3K), which is active as a heterodimer of regulatory and catalytic subunits and may be inhibited by an excess of free regulatory subunits. Alternative splicing of the Pik3r1 gene yields the three PI3K regulatory isoforms p85a, p55a and p50a. Since little is known how PI3K is regulated in pancreatic beta-cells, we examined signalling by p85a, p55a and p50a in insulinoma cells (INS-1E) stimulated by IGF-1. PI3K regulatory isoforms p85a, p55a and p50a were…

Schlagworte

Apoptosis Alternative Splicing Antibodies Diabetologie und Stoffwechsel